AI assistant
Sending…
BerGenBio — Director's Dealing 2023
Nov 21, 2023
3555_dirs_2023-11-21_72524bf9-6147-4307-ad73-a1f12804f8bd.pdf
Director's Dealing
Open in viewerOpens in your device viewer
| K R T - 1 5 0 0 T e m pla t e f o r n o tific a tio n o f t r a n s a c tio n s b y |
|---|
| p e r s o n s dis c h a r gin g m a n a g e rial r e s p o n sibilitie s ( PDM R ) |
| a n d p e r s o n s clo s ely a s s o cia t e d wit h t h e m |
LEI number 213800TYYFXKYF3V2A23
| The person liable: | |||||
|---|---|---|---|---|---|
| PDMR | person) | Closely associated person (natural | person) | Closely associated person (legal | |
| Info about the one who reports | |||||
| Last name | OPSVIK | ||||
| First name | OLVE | ||||
| Business name | |||||
| About PDMR | |||||
| Last name | Tullgren | ||||
| First name | Anders | ||||
| Position / role | Chairman of the board | ||||
| Initial notification or amendment to prior notification | |||||
| Initial | Amendment | ||||
| Details about the issuer or emission allowance market participant | |||||
| Business name | BerGenBio A S A |
||||
Skjema versjon: 46345
K R T - 1 5 0 0 T e m pla t e f o r n o tific a tio n o f t r a n s a c tio n s b y p e r s o n s dis c h a r gin g m a n a g e rial r e s p o n sibilitie s ( PDM R ) a n d p e r s o n s clo s ely a s s o cia t e d wit h t h e m
11/20/2023 7:04:27 PM AR579371194
| Description of the financial instrument/type of instrument | |||||||
|---|---|---|---|---|---|---|---|
| Instrument | Financial instrument linked to a share or a debt instrument | ||||||
| ISIN code | NO0012921495 | ||||||
| Name of the financial instrument | |||||||
| Warrants (ISIN NO0012921495). | |||||||
| Nature of the transaction | |||||||
| Transaction type | Other transaction type | ||||||
| Description of transaction type | |||||||
| Exercise of warrants with ISIN NO0012921495 relating to shares in BerGenBio A SA with ISIN NO0010650013. |
|||||||
| Share option program | |||||||
| The transaction is linked to an excersise of a share option program Yes No |
|||||||
| Currency of the transaction | |||||||
| Currency | NOK | ||||||
| Price(s) and volume(s) | |||||||
| Price per unit | 0.13 | ||||||
| Volume | 704 910 | ||||||
| Aggregated information | |||||||
| Average price per unit | 0.13000 | ||||||
| Aggregated volume | 704 910 | ||||||
| Total amount | 91 638.300000 | ||||||
| Date of the transaction | |||||||
| Date | 11/20/2023 | ||||||
| Place of the transaction | |||||||
| Trading venue | XOFF - Outside a trading venue | ||||||
| Comment |
More from BerGenBio
M&A Activity
2025
Oct 29
Delisting Announcement
2025
Oct 29
Capital/Financing Update
2025
Oct 28
M&A Activity
2025
Oct 24
Share Issue/Capital Change
2025
Sep 17
Share Issue/Capital Change
2025
Sep 17
Interim / Quarterly Report
2025
Aug 20
Earnings Release
2025
Aug 20
Share Issue/Capital Change
2025
Aug 5
Declaration of Voting Results & Voting Rights Announcements
2025
Aug 4